WORLD Indian COVID-19 vaccine panel chief says Biological E vaccine 90 pct effective

WORLD

Indian COVID-19 vaccine panel chief says Biological E vaccine 90 pct effective

Xinhua

16:53, June 17, 2021

A health worker administers Covishield, Serum Institute of India's version of the AstraZeneca vaccine, during a drive-in vaccination program in Kolkata, India, Wednesday, June 16, 2021. (Photo: AP)

NEW DELHI, June 17 (Xinhua) -- Head of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI), Dr N K Arora said Biological E's made-in-India vaccine is expected to have 90 percent effectiveness against COVID-19 and will likely be a gamechanger in the fight against the pandemic.

Arora in an interview to a local television news channel NDTV Thursday said the vaccine is entering Phase 3 trials and could be available by October.

According to Arora, Biological E's vaccine -- to be called Corbevax -- is similar to the Novavax vaccine.

Biological E will be out likely in October with an efficacy matching Novavax's.

India started the vaccination against COVID-19 on January 16 by administrating two made-in-India vaccines -- Covishield and Covaxin.

Of late Russian COVID-19 vaccine -- Sputnik V too was rolled out in the country.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue